CoChat

Chatbots in the fight against the COVID-19 pandemic

Open access
Miner, Adam S., Laranjo, Liliana, Kocaballi, A. Baki · 2020 · npj Digital Medicine

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index; 17 of the 51 sources its claims cite were checked for support.

Abstract

During the novel coronavirus (COVID-19) pandemic, institutions like the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have begun utilizing chatbots to share information, suggest behavior, and offer emotional support 1 , 2 . The CDC has named theirs “Clara” (Fig. 1 ). Chatbots are software programs that talk with people through voice or text in their natural language 3 , 4 . Some well-known examples include “Alexa” from Amazon, “Siri” from Apple, and “Cortana” from Microsoft. They often come pre-installed on smartphones or home-based smart speakers 5 . In recent years, chatbot use for health-related purposes has increased considerably, from supporting clinicians with clinical interviews and diagnosis to aiding consumers in self-managing chronic conditions 6 . While promising, the use of chatbots may pose safety risks. Chatbots have varied widely in their responses to questions about physical health, suicide, intimate partner violence, substance abuse, and other sensitive conversations 4 , 6 , 7 , 8 , 9 . In one study, about a third (29%) of chatbot responses to health questions could have caused harm, and about half of those (16%) could have resulted in death if acted upon 9 . The COVID-19 pandemic puts in stark relief the potential for chatbots to help save lives.

Overview

CoChat Summary

TL;DR

Chatbots, if effectively designed and deployed, could help fight the COVID-19 pandemic by disseminating up-to-date information, encouraging health-protective behaviors, and mitigating the psychological harm of fear and isolation. However, the risk of amplifying misinformation and the lack of prior effectiveness research in pandemic contexts are serious concerns requiring immediate collaboration among healthcare workers, companies, academics, and governments.

Key findings

This is a perspective/commentary piece, not an empirical study, so it reports no original data; its claims are supported by cited literature.

  • Chatbots may be uniquely suited to pandemic response across four functions: information dissemination, symptom monitoring, behavior change support, and mental health support.
  • Prior research cited suggests people are more willing to disclose sensitive personal symptom information to a chatbot than to a human, which could improve triage and population-level infection estimates.
  • Safety concerns are documented from prior work: in one cited study, about a third (29%) of chatbot responses to health questions could have caused harm, and about half of those (16%) could have resulted in death if acted upon.
  • Cited evidence on pandemic mental health harm: the 2003 SARS outbreak produced a "mental health catastrophe" in which 59% of a hospitalized cohort developed a diagnosable psychiatric disorder, and after 30 months less than half had psychologically recovered.

Methods

Not stated in the paper (no empirical design, sample, or analysis); this is a narrative perspective article synthesizing cited literature and current chatbot deployments.

  • Draws on cited studies of chatbot health responses, disclosure behavior, and pandemic psychology, plus examples of deployed COVID-19 chatbots (CDC's "Clara," WHO's WhatsApp health alert, and corporate/government chatbots).
  • Organizes the argument around pandemic challenges, special features of pandemics, four chatbot affordances, and corresponding challenges.

Limitations

Stated by the paper: chatbots are untested in pandemics and have demonstrated limits in health crisis detection and response; long-term mental health outcomes of chatbot use are unclear and worthy of future investigation; challenges addressed only in real time during a crisis may lead to erroneous outputs from lack of testing; developers must decide whose voice to amplify amid conflicting global/local advice; third-party "skills" raise data-sharing concerns with unknown consequences; symptom screening tests constitutional and regulatory boundaries (e.g., reported digital contact tracing exploration in the US and Israel).

  • Evident from the text: the article presents no original data or evaluation, so its claims about chatbot effectiveness rest on extrapolation from non-pandemic contexts and cited prior work.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41746-020-0280-0

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Coronavirus chatbot user interface. Chatbot publicly available at Centers for Disease Control and Prevention (CDC) website: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html (Captured 13 Apr 2020).
Fig. 1 Coronavirus chatbot user interface. Chatbot publicly available at Centers for Disease Control and Prevention (CDC) website: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html (Captured 13 Apr 2020).CC BY · PubMed Central

Verification

Claims the paper makes

8 Valid · 0 Not valid · 24 Not checked · 15 Own results and interpretations

16 more claims

Create a free account to see all 47 claims and to verify the 34 references still open.

See all claims — free account
  • Probably not a substantial claim. 15
  • It may state two separate claims as one. 14

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 23 references

Cited by

See all 393

Metadata

Authors
Miner, A. S., Laranjo, L., & Kocaballi, A. B.
Affiliations
  • Stanford University (US)
  • Macquarie University (AU)
  • University of Technology Sydney (AU)
Corresponding author
Miner, Adam S.
Venue
npj Digital Medicine
Published
2020-05-04
Volume
3
Issue
1
Pages
65-65
ISSN
2398-6352 (ISSN-L)
OpenAlex
W3021999948
Cited by
322
References
22
Citations by year
2026: 26 · 2025: 28 · 2024: 38 · 2023: 47 · 2022: 79 · 2021: 82 · 2020: 22
FWCI
16.92
Type
journal article
Language
en
Open access
Licence
Locations
  • npj Digital Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UTS ePRESS (University of Technology Sydney) (submittedVersion, other-oa)
Funders
  • National Institutes of Health (KL2TR001083, UL1TR001085, UL1TR003142, KL2TR003143)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
Keywords
chatbots, COVID-19 pandemic, health data sharing, emotional support, chatbot safety, suicide prevention, intimate partner violence, substance abuse, clinical decision support

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chatbots in the fight against the COVID-19 pandemic. https://app.cochat.ai/papers/10.1038/s41746-020-0280-0
The paper
Miner, A. S., Laranjo, L., & Kocaballi, A. B. (2020). Chatbots in the fight against the COVID-19 pandemic. npj Digital Medicine. https://doi.org/10.1038/s41746-020-0280-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.